ASRT
Price
$0.63
Change
+$0.03 (+5.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
91.13M
17 days until earnings call
INDV
Price
$10.74
Change
+$1.29 (+13.65%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.91B
Earnings call today
Ad is loading...

ASRT vs INDV

Header iconASRT vs INDV Comparison
Open Charts ASRT vs INDVBanner chart's image
Assertio Holdings
Price$0.63
Change+$0.03 (+5.00%)
Volume$299
Capitalization91.13M
Indivior
Price$10.74
Change+$1.29 (+13.65%)
Volume$46.79K
Capitalization2.91B
ASRT vs INDV Comparison Chart
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. INDV commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a StrongBuy and INDV is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ASRT: $0.60 vs. INDV: $9.45)
Brand notoriety: ASRT and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 57% vs. INDV: 60%
Market capitalization -- ASRT: $91.13M vs. INDV: $2.91B
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 6 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • ASRT’s TA Score: 6 bullish, 2 bearish.
  • INDV’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, both ASRT and INDV are a good buy in the short-term.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а -3.22% price change this week, while INDV (@Pharmaceuticals: Other) price change was +4.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.61%. For the same industry, the average monthly price growth was -4.57%, and the average quarterly price growth was -11.30%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

INDV is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than ASRT($91.1M). INDV has higher P/E ratio than ASRT: INDV (2102.00) vs ASRT (1.21). INDV YTD gains are higher at: -23.974 vs. ASRT (-30.995). INDV has higher annual earnings (EBITDA): 66M vs. ASRT (-222.9M). INDV has more cash in the bank: 410M vs. ASRT (73.4M). ASRT has less debt than INDV: ASRT (39.7M) vs INDV (282M). INDV has higher revenues than ASRT: INDV (1.09B) vs ASRT (152M).
ASRTINDVASRT / INDV
Capitalization91.1M2.91B3%
EBITDA-222.9M66M-338%
Gain YTD-30.995-23.974129%
P/E Ratio1.212102.000%
Revenue152M1.09B14%
Total Cash73.4M410M18%
Total Debt39.7M282M14%
FUNDAMENTALS RATINGS
ASRT vs INDV: Fundamental Ratings
ASRT
INDV
OUTLOOK RATING
1..100
671
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9261
PRICE GROWTH RATING
1..100
8764
P/E GROWTH RATING
1..100
9898
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASRT's Valuation (81) in the Pharmaceuticals Major industry is in the same range as INDV (100) in the null industry. This means that ASRT’s stock grew similarly to INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (68) in the null industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that INDV’s stock grew similarly to ASRT’s over the last 12 months.

INDV's SMR Rating (61) in the null industry is in the same range as ASRT (92) in the Pharmaceuticals Major industry. This means that INDV’s stock grew similarly to ASRT’s over the last 12 months.

INDV's Price Growth Rating (64) in the null industry is in the same range as ASRT (87) in the Pharmaceuticals Major industry. This means that INDV’s stock grew similarly to ASRT’s over the last 12 months.

INDV's P/E Growth Rating (98) in the null industry is in the same range as ASRT (98) in the Pharmaceuticals Major industry. This means that INDV’s stock grew similarly to ASRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTINDV
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEYYX8.54N/A
N/A
Macquarie Climate Solutions Y
CCALX67.71N/A
N/A
Conestoga Small Cap Institutional
REEBX53.25N/A
N/A
American Funds Europacific Growth R2E
LICFX15.43N/A
N/A
Lord Abbett International Equity F
LMCRX29.91N/A
N/A
Lord Abbett Mid Cap Stock R3

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and OGI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
+2.12%
OGI - ASRT
28%
Poorly correlated
+1.89%
INDV - ASRT
26%
Poorly correlated
+7.26%
COLL - ASRT
25%
Poorly correlated
-3.42%
AQST - ASRT
25%
Poorly correlated
+2.18%
KMDA - ASRT
25%
Poorly correlated
+1.70%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+7.26%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
+2.12%
MKKGY - INDV
24%
Poorly correlated
+1.11%
TEVA - INDV
22%
Poorly correlated
+2.07%
PAHC - INDV
22%
Poorly correlated
+0.76%
More